Another study of Toshiyuki Seki etc. highlighted the role of interleukin 6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma, as IL-6 induced VEGF production by tumor cells and consequently activated angiogenesis [27]. The gene discussed is VEGFA; the disease is neoplasm.